New hope for kids with psoriasis: drug trial targets severe skin symptoms
NCT ID NCT05565560
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 32 times
Summary
This study tests a drug called apremilast in Japanese children aged 6 to 17 with moderate to severe plaque psoriasis. The goal is to see if it can clear or nearly clear their skin by week 16. Participants must have tried topical treatments without success and be candidates for stronger therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dokkyo Medical University Hospital
Shimotsuga-gun, Tochigi, 321-0293, Japan
-
Fukuoka University Hospital
Fukuoka, Fukuoka, 814-0180, Japan
-
Fukushima Medical University Hospital
Fukushima, Fukushima, 960-1295, Japan
-
Gifu University Hospital
Gifu, Gifu, 501-1194, Japan
-
Gunma University Hospital
Maebashi, Gunma, 371-8511, Japan
-
Hokkaido University Hospital
Sapporo, Hokkaido, 060-8648, Japan
-
Hospital of the University of Occupational and Environmental Health, Japan
Kitakyushu-shi, Fukuoka, 807-8556, Japan
-
Kanazawa Medical University Hospital
Kahoku-gun, Ishikawa-ken, 920-0293, Japan
-
Kansai Medical University Hospital
Hirakata-shi, Osaka, 573-1191, Japan
-
Kindai University Hospital
Osakasayama-shi, Osaka, 589-8511, Japan
-
Kurume University Hospital
Kurume-shi, Fukuoka, 830-0011, Japan
-
Mita Dermatology Clinic
Minato-ku, Tokyo, 108-0014, Japan
-
Nagasaki University Hospital
Nagasaki, Nagasaki, 852-8501, Japan
-
Nagoya City University Hospital
Nagoya, Aichi-ken, 467-8602, Japan
-
Nippon Life Hospital
Osaka, Osaka, 550-0006, Japan
-
Saruwatari Dermatology Clinic
Kagoshima, Kagoshima-ken, 890-0046, Japan
-
Seibo International Catholic Hospital
Shinjuku-ku, Tokyo, 161-8521, Japan
-
Shinshu University Hospital
Matsumoto-shi, Nagano, 390-8621, Japan
-
St Lukes International Hospital
Chuo-ku, Tokyo, 104-8560, Japan
-
St Marianna University Hospital
Kawasaki-shi, Kanagawa, 216-8511, Japan
-
Sugai Dermatology Park Side Clinic
Utsunomiya, Tochigi, 321-0954, Japan
-
Takagi Dermatological Clinic
Obihiro-shi, Hokkaido, 080-0013, Japan
-
Takamatsu Red Cross Hospital
Takamatsu, Kagawa-ken, 760-0017, Japan
-
Takeoka Dermatology Clinic
Marugame-shi, Kagawa-ken, 763-0074, Japan
-
Teikyo University Hospital
Itabashi-ku, Tokyo, 173-8606, Japan
-
Tokai University Hospital
Isehara-shi, Kanagawa, 259-1193, Japan
-
Tokyo Medical University Hospital
Shinjyuku-ku, 160-0023, Japan
-
University Hospital Kyoto Prefectural University of Medicine
Kyoto, Kyoto, 602-8566, Japan
-
University of the Ryukyus Hospital
Ginowan-shi, Okinawa, 901-2725, Japan
Conditions
Explore the condition pages connected to this study.